Trump Backs Down from High EU Pharma and Semiconductor Tariffs

US President Donald Trump has reversed plans to impose extremely high tariffs on pharmaceuticals (up to 250%) and semiconductors (up to 100%) imported from the European Union (EU).

Key Points

• New Agreement: According to updated US-EU deal details, tariffs on EU pharmaceuticals and semiconductors are now capped at 15%, matching most other sectors covered by the trade deal.

• EU Conditions: To reduce car export tariffs from 27.5% to 15%, the EU must first pass legislation cutting US export tariffs to zero.

• Previous Threats: In July, Trump threatened to raise pharmaceutical tariffs to 200%, and on August 5, he said they could go as high as 250%, emphasizing the desire to favor US-made medicines.

Impact of the Deal

• Ireland: As a major pharmaceutical exporter to the US, Ireland welcomed the 15% tariff cap, providing protection for exporters.

• Reciprocity: The EU will drop tariffs on all US industrial goods, including agricultural products like fresh fruit, vegetables, pork, bison meat, and tree nuts.

• Car Tariffs: EU car tariffs will drop to 15%, retroactively from the start of the month in which the legislative process begins.

Industry Effects

• The automotive industry still faces significant costs, having paid millions of euros in tariffs daily since April.

• Wine and spirits exporters are disappointed as they remain subject to EU and US tariffs, affecting future growth planning and adding pressure on US bars and restaurants.

Conclusion

The revised US-EU trade deal provides stability and predictability for businesses and consumers while reducing the risk of extreme tariffs. However, challenges remain for the automotive and wine/spirits sectors, and EU legislation is essential for full implementation.